Genital herpes is an infectious disease which is caused due to Herpes Simplex Virus of the genitals. Most of the people who suffer from this infection either have no symptoms or mild symptoms. Common symptoms include small blisters that break open and form ulcers at particular area. Moreover, flu like symptoms such as fever, aching, and swollen lymph nodes can be observed. Drugs such as Acyclovir and Famciclovir are used treatment of genital herpes. These medications help to prevent herpes sores & blisters. Moreover, these drugs can be used in the treatment of outbreak of genital herpes and to reduce future complications.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the genital herpes treatment market.
Top Impacting Factors
- Rise in prevalence of sexually transmitted diseases, rise in usage of herpes treatment, increase in awareness regarding sexually transmitted diseases, increase in usage of targeted herpes treatment procedures, surge in hospital acquired infections, and increase in demand for effective therapeutic treatment are the key factors that drive the growth of the market.
- In addition, surge in government funding to develop innovative treatment for genital herpes, increase in demand of minimally invasive treatment procedures, rise in developments of anti-viral resistant species, R & D activities to improve quality of drug treatment methods, and joint ventures & collaboration between key market players are some factors, that drive the growth of the market.
- However, lack of diagnostic tests and social stigma associated with treatment hinder the growth of the market.
- Contrarily, government support for regulatory approvals and awareness campaigns regarding sexual transmitted diseases are expected to offer lucrative opportunities for the expansion of the market.
Market Trends
New Product Launches to Flourish the Market
In 2020, OrganiCare announced launch of its new product FemiClear. This medication is over the counter and used in treatment of genital herpes symptoms.
In 2020, Perrigo announced launch of its AB rated generic Zovirax cream. This product content acyclovir and can used to reduce further complications in genital herpes.
Key Benefits of the Report
- This study presents the analytical depiction of genital herpes treatment market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Genital Herpes Treatment Market Report
- Which are the leading players active in the genital herpes treatment market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is "genital herpes treatment"?
- What is "genital herpes treatment" market prediction in the future?
- Who are the leading global players in the "genital herpes treatment" market?
- What are the current trends and predicted trends?
- What are the key benefits of the "genital herpes treatment" market report?
Genital Herpes Treatment Market Report Highlights
| Aspects | Details |
 By Drug Type |
|
 By Route of Administration |
|
 By Indication |
|
 By Distribution Channel |
|
 By Region |
|
 Key Market Players | Dr. Reddy’s Laboratories Ltd., Teva Pharmaceuticals Inc, GlaxoSmithKline, Mylan Pharmaceuticals Inc., Hospira Inc., Apotheca Inc., Sandoz Inc., Vical, Novopharm Ltd., Maruho, Novartis AG, AiCuris, Genocea Biosciences |
Loading Table Of Content...
